Internet Activities

Paradigm has experience in the customized design of interactive web portals that provide learners with CME-certified, on-demand activities, many of which are a core component of our multi-platform initiatives. These web sites incorporate online registration for upcoming live events, host enduring activities for up to 2 years, and make available additional educational tools and references. Below are a few samples of our more recent sites.

To view our on-demand, online activities, please click here

 

EXPERT STRATEGIES FOR FACIAL REJUVENATION UTILIZING LONGER-ACTING DERMAL FILLERS

In the demanding field of aesthetic medicine, insufficient knowledge and skills can contribute to improper treatment and inferior patient outcomes with regard to efficacy and safety. A significant gap exists between the need for quality education and training for those interested in advanced practice of facial rejuvenation and the expert training that is currently available. This is especially true regarding longer-lasting soft tissue fillers. Clinicians clearly want and need additional education on the safe and effective use of these agents. This CME-certified activity will pay particular attention to advanced uses of longer-lasting soft tissue fillers as a fundamental component of individualized facial rejuvenation.

 

INDIVIDUALIZING TYPE 2 DIABETES TREATMENT: APPLYING THE LATEST EVIDENCE IN CONSIDERATION OF PATIENT CHARACTERISTICS

A 2-hour, live satellite symposium will feature practical, evidence-based insights by recognized expert clinicians on how to implement guidelines for individualizing T2DM management, evaluate benefit/risk profiles of newer T2DM therapies, and assess effects of newer T2DM therapies on macrovascular (eg, atherosclerotic cardiovascular disease) and microvascular (eg, chronic kidney disease) outcomes. Included in the agenda are didactic lectures, interactive case studies, and a faculty Q&A session. The symposium will be enhanced by an audience response system feature, which allows attendees to interact with the faculty about their experiences managing patients with T2DM.

 

CONFRONTING CHALLENGES IN PLAQUE PSORIASIS MANAGEMENT: CHOICES, CONTROVERSIES, AND CASE STUDIES

This educational webinar describes current knowledge of the inflammatory pathways involved in the pathophysiology of psoriasis and how newer biologic agents target these pathways for effective disease management. The case-based faculty discussion illustrates practical application of the science to guideline-accordant treatment of psoriasis, keeping in mind individual disease manifestations and possible comorbidities.

 

DIAGNOSIS AND TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION: EARLIER IS BETTER

In "Diagnosis and Treatment of Myopic Choroidal Neovascularization: Earlier Is Better," a 1-hour interactive audio webinar for comprehensive ophthalmologists and optometrists, the expert faculty of Sunir J. Garg, MD, and Mark T. Dunbar, OD, reviews the pathology and symptoms of mCNV; makes evidence-based diagnostic recommendations for detecting disease as early as possible; compares distinguishing features of anti-VEGF agents commonly used to treat mCNV, including ease of administration, available formulations, and cost-effectiveness; and evaluates recently reported data on the safety, efficacy, and treatment durability of anti-VEGF agents for treating mCNV. The program's educational objectives are augmented by 1) video demonstration of intraocular injection of anti-VEGF agents and 2) presentation of interactive case studies of myopic choroidal neovascularization.

 

UPDATES ON THE TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION: EARLIER INTERVENTION IS BETTER

Eye care specialists frequently cite challenges in providing prompt, accurate diagnosis and early treatment as obstacles to providing optimal care for patients with (mCNV). In particular, challenges relating to the differential diagnosis of mCNV must be overcome so that treatment can be initiated early enough to avoid permanent vision loss.

Anti-vascular endothelial growth factor (VEGF) therapies are recommended as first-line for treatment of this condition; however, retina specialists and comprehensive ophthalmologists might not be up-to-date on clinical trial data relating to the efficacy, safety, cost-effectiveness, and convenience of use of various anti-VEGF agents. The proposed educational activity will provide a case-enhanced, expert-led review of evidence-based treatment of mCNV to help physicians with the optimal management of this condition.

 

EMERGING THERAPIES IN THE TREATMENT OF MILD-TO-MODERATE ATOPIC DERMATITIS

This initiative consists of a series of live satellite symposia and an enduring webinar that includes video of faculty presentations synced with PowerPoint slides along with embedded interactive polling questions. These activities provide dermatology clinicians with relevant information on the role of immune abnormalities and skin-barrier dysfunction in the development of AD and how this understanding informs and can help guide treatment selection. Expert faculty discuss the recent guidelines for diagnosis and management of AD, and summarize data on current and emerging topical and systemic therapies to help providers optimize treatment outcomes.

 

ADVANCES IN HEART FAILURE PHARMACOTHERAPY

"Advances in Heart Failure Pharmacotherapy" is a 1-hour interactive Webinar developed from a video recording of a live presentation on managing heart failure (HF), an installment of the "Tall Rounds" series of the Cleveland Clinic's Heart and Vascular Institute. An expert multidisciplinary faculty answers a number of crucial management questions in their presentation: How should novel medications be incorporated into the careof HF patients? When should aldosterone receptor antagonists be instituted? When can the combination agent sacubitril/valsartan be considered? What about ivabradine? What are various characteristics of these novel agents - a verse effects, dosage titration, and contraindications? Last, how can multidisciplinary care teams produce better outcomes, as evidenced in part by the Cleveland Clinic experience? These topics are made more immediate and practical through the use of an actual Cleveland Clinic HF case and participant-interactive polling questions.

 

SEQUENCING AND TRANSITIONS FOR ADVANCED RENAL CELL CARCINOMA: LEVERAGING THE LATEST TOOLS AND MANAGING COMPLICATIONS

This interactive webinar provides clinicians who treat patients with advanced renal cell carcinoma (RCC) with expert guidance regarding the mechanisms of action (MOAs) for currently available agents, optimal selection and sequencing of therapies with different MOAs, and management of adverse events associated with treatments for advanced RCC. This activity includes patient advocate audio clips, a MOA video, embedded interactive polling questions, and links to clinician and patient educational resources.

 

THE ACADEMY FOR THE ADVANCEMENT OF AESTHETICS: BOTULINUM TOXIN TYPE A

AestheticCare.org provides CME-certified learning modules developed by physicians who are experts in the field of aesthetic medicine. The courses are easy to navigate, providing comprehensive insight and information, helping aesthetic clinicians face the constant challenge of keeping ahead of the curve with evolving techniques and a broadening array of available products. The site also includes animated and live demonstrations of injection technique, as well as detailed images and descriptions of facial anatomy, designed to promote safe and effective use of available treatment options.

 

RHEUMATOID ARTHRITIS: CHALLENGES AND OPPORTUNITIES IN THE EVOLVING TREATMENT LANDSCAPE

This expert interview on rheumatoid arthritis is a case-illustrated review of the treatment of moderate to severe disease using the 2015 American College of Rheumatology guidelines, focusing on the assessment of disease activity to guide therapy decisions. The roles of newly approved and emerging agents in the treatment armamentarium and the management of rheumatoid arthritis in patients with comorbidities are also highlighted in the informative discussion with the host.

 

PSORIATIC ARTHRITIS: UNDERSTANDING THE ROLE OF NEW AND EMERGING THERAPIES TARGETING THE INFLAMMATORY CASCADE

This interactive, case-based, web monograph provides a comprehensive review of psoriatic arthritis (PsA) and is enhanced by a pathophysiology video that illustrates how the cytokine network is active in inflammation, joint destruction, and new bone formation and how established, newly approved, and emerging biologic agents specifically target cytokine drivers of inflammation and joint destruction. Expert rheumatology faculty review diagnostic criteria, monitoring PsA activity, applying treat-to-target guidelines, relevant clinical efficacy and safety data for new and emerging agents, and the implications of comorbidities in managing PsA.

 

MANAGING ADVANCED BLADDER CANCER: THE UROLOGIST'S PERSPECTIVE

During this interactive and engaging symposium, experts in the field will provide the most recent evidence regarding selection of patients with advanced bladder cancer for neoadjuvant chemotherapy, as well as address concerns surrounding chemotherapy before surgery. In addition, current data on emerging immune checkpoint inhibitors, including potential future applications in the neoadjuvant and adjuvant setting, will be presented. Strategies for implementing multidisciplinary approaches and shared decision making in clinical practice will also be provided.

 

COMBATING MULTIDRUG-RESISTANT ORGANISMS: STRATEGIC CONSIDERATIONS FOR OPTIMAL CLINICAL OUTCOMES

After a long dry spell, the antibiotic pipeline is showing signs of resurgence. To withstand resistance in the coming years, infectious disease clinicians will be called on to optimize the use of new agents, and to lead antimicrobial stewardship efforts, which have become urgent professional and government priorities. Doing so will require a thorough understanding of multidrug-resistant pathogens, their mechanisms of resistance, and the role and function of new antibiotics in surmounting the growing problem of resistant infections. Our distinguished panel of infectious disease experts will address these critical issues in an engaging, interactive, case-based, format.

 

GIANT-CELL ARTERITIS: THE PROMISE OF EARLIER DIAGNOSIS AND TARGETED THERAPY

Early diagnosis of giant cell arteritis is critical to preventing blindness and other complications of this potentially debilitating rheumatologic disease, which afflicts predominantly older women and men. The expert faculty for this monograph will compare the 2 variants of this disease, review imaging techniques, and describe findings suggestive of giant cell arteritis, all with an eye toward expediting diagnosis. Also to be discussed: insights on tapering glucocorticoid therapy while avoiding relapse and medication-related adverse events, and the potential role of emerging second-line therapies.

This activity expired for credit on April 22, 2017

 

GIANT-CELL ARTERITIS: NEW FINDINGS ON DIAGNOSTIC STRATEGIES AND EMERGING THERAPIES

Giant cell arteritis is a potentially debilitating rheumatologic disease that afflicts predominantly older men and women. Early diagnosis and vigilant management of the disease are critical to preventing or halting vision loss. The expert faculty for this webinar will discuss strategies for diagnosis, initial treatment, and management of giant cell arteritis. The overall prognosis for the disease will be discussed, as will emerging second-line therapies that may soon provide additional treatment options.

This activity expired for credit on April 1, 2017

 

DIAGNOSING AND MANAGING IRRITABLE BOWEL SYNDROME IN FAMILY PRACTICE: THE LATEST NEWS AND PATIENT VIEWS

The personalized care and therapeutic relationship required for optimal IBS management resides firmly within the purview of family practitioners (FPs), who are known for their care and concern for the whole patient. This program was designed to increase FP awareness of updated diagnostic criteria, new diagnostic tools, and new treatment paradigms through the use of case-based scenarios, and to translate specialist-focused recommendations into family practice, fostering better care of patients with IBS, who often feel frustrated and unheard during clinical encounters.

This activity expired for credit on September 22, 2016


CD30 IN LYMPHOMA: AN INCREASINGLY IMPORTANT ROLE IN TESTING AND TARGETING

A large number of ongoing trials evaluating brentuximab vedotin (BV) indicate it has the potential to treat an increasing diversity of CD30-positive lymphomas. This video webinar delivers critical information about CD30-positive lymphomas, including the role of CD30 testing, the role of the pathologist in diagnosis, and the use of CD-30 targeted antibody-drug conjugates based on their mechanism of action (MOA) and efficacy and safety data from late-phase clinical trials. Developed from the proceedings of a live grand rounds meeting, this webinar incorporates case-based scenarios, MOA animation, and interactive polling questions to deliver critical information about CD30-positive lymphomas to community hematologists/oncologists and pathologists alike, arming them with the information they need to optimally manage patients with CD30-positive lymphomas.

 

ADVANCES IN ENERGY-BASED NONSURGICAL TISSUE LIFTING: HISTORICAL PERSPECTIVES, PRACTICAL APPLICATIONS, AND CLINICAL PEARLS

This CME-certified webinar was designed to educate learners about energy-based tissue lifting techniques, where they "fit" within the rejuvenation continuum, and how to select appropriate patients.

 

CONFRONTING CHALLENGES IN PLAQUE PSORIASIS MANAGEMENT: CHOICES, CONTROVERSIES, AND CASE STUDIES

Psoriasis is a disorder that requires optimal care by clinicians who understand how to treat patients as individuals based on their personal and disease characteristics, as well as the nuances of available agents. This webinar features dermatology experts describing how to tailor psoriasis therapy based on pathophysiology, disease symptoms, and patient goals; illustrating the incorporation of newly approved biologic agents for moderate and severe disease. The faculty discussion of the interactive polling questions and cases provides practical clinical insights on management of psoriasis.

 

APPLYING GUIDELINE RECOMMENDED AND RECENT EVIDENCE-BASED THERAPIES IN THE TREATMENT OF CHRONIC HEART FAILURE

As the US population ages, more patients are being diagnosed with chronic heart failure (HF). There are established standard-of-care medications, but use of them has been shown to be suboptimal. In the last year, novel therapies have become available, but many clinicians are unclear on their role in the management of chronic HF. In addition, many clinicians want a greater understanding of the underlying pathophysiology of chronic HF. The live symposium and online monograph "Applying Guideline-Recommended and Recent Evidence-Based Therapies in the Treatment of Chronic Heart Failure" will arm cardiologists, primary care providers, hospitalists, emergency medicine specialists, and other clinicians with the information they need to effectively manage chronic HF in a range of patients. The expert faculty will describe the pathophysiology of chronic HF, differentiating between HF with reduced or preserved left ventricular ejection fraction. The faculty will review the most recent updates to evidence-based treatment guidelines, focusing on recommendations for pharmacologic management, and will describe the mechanisms of action of, clinical evidence for, and appropriate use of newer chronic HF therapies.

This activity expires for credit on April 19, 2018

 

DELVING DEEPER INTO THE COMPLEXITIES AND PERPLEXITIES OF ORAL ANTICOAGULATION

You've reached the decision to move away from warfarin and prescribe a novel oral anticoagulant (NOAC) for your patient, to reduce the risk of stroke in nonvalvular atrial fibrillation or to prevent or treat venous thromboembolism. But next steps can be daunting: With which 1 of 4 available NOACs do you individualize therapy? At what dosage? Will age, renal function, or concomitant medications factor into your strategy? And what protocols and agents do you employ when it's necessary to reverse anticoagulation in a patient taking a NOAC who is bleeding or requires surgery? Through challenging case reviews, three experts from Harvard's Brigham and Women's Hospital answer these and other questions about providing safe and efficacious use of NOACs.

This activity expires for credit on January 26, 2018

 

THE ROLE OF EMERGING THERAPIES IN THE MANAGEMENT OF PEMPHIGUS VULGARIS

Pemphigus vulgaris (PV) is a rare autoimmune mucocutaneous blistering disease associated with significant morbidity when not treated promptly. The advent of corticosteroids largely eliminated the mortality risk associated with pemphigus, but exposes patients to risk of bone loss and infection and is contraindicated in some patients. While the rarity of this disease has challenged the development of randomized controlled trials, other agents have shown promise. This interactive web monograph provides an overview of PV and its diagnosis and current treatment as well as data on the safety and efficacy of emerging adjuvant and alternative therapies such as mycophenolate mofetil, intravenous immunoglobulins, rituximab, dapsone, and methotrexate.

This activity expired for credit on April 29, 2107

 

THE EVOLVING ROLE OF ORAL ANTICOAGULATION IN INTERNAL MEDICINE: NVAF, DVT, AND PE BEST PRACTICES

Internal medicine clinicians (IMs) are on the frontlines of managing patients who are eligible for direct oral anticoagulant (DOAC) therapy, including those with nonvalvular atrial fibrillation (NVAF) who are at risk for stroke, and those with venous thromboembolism, including deep vein thrombosis (DVT) and/or pulmonary embolism (PE), who may be at risk for recurrence. This educational initiative, "The Evolving Role of Oral Anticoagulation in Internal Medicine: NVAF, DVT, and PE Best Practices," provides expert-led, evidence-based guidance on the practical, safe, and effective use of DOACs for the optimal treatment of eligible patients in internal medicine. This case-based education will help IMs tailor DOAC use to a variety of clinical scenarios, including special patient populations (eg, elderly or renally impaired patients), while contemplating a broad range of important considerations related to the indications, contraindications, dosing, and pharmacology of the individual agents. It will also address the management of DOACs in the presence of common clinical challenges such as bleeding or the need for surgery.

This activity expires for credit on July 6, 2017

 

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): BETTER BREATHING BEGINS IN INTERNAL MEDICINE

Many clinicians are not aware of or do not apply evidence based guideline recommendations to identify COPD patients early and accurately. Clinicians face challenges when selecting appropriate maintenance therapy and often don't ensure adherence to inhaled COPD medications. This live, interactive CME-certified satellite symposium held at Internal Medicine 2016 and text-based, CME-certified web monograph, featuring audio and video clips of faculty interviews, discussions, and therapeutic device administration demonstration will help internists better apply recommended diagnostic tools, develop appropriate individualized maintenance treatment and recognize strategies to improve adherence to COPD maintenance therapy.

 

UNCOVERING THE NUANCES OF ORAL ANTICOAGULATION FOR OPTIMAL MANAGEMENT OF HOSPITALIZED PATIENTS

During this CME-certified symposium, expert faculty will provide guidance - via didactic lecture and interactive case studies - on how to identify at-risk patients who are candidates for oral anticoagulation therapy in the hospital setting. Through the use of iPad technology to enhance the learning experience, participants will be provided with evidenced-based information allowing for differentiating among the oral anticoagulants, selecting the most appropriate oral anticoagulant for at-risk patients based on individual drug and patient characteristics; and understanding strategies for stopping and reinitiating anticoagulation in patients undergoing surgical procedures.

This activity expired for credit on April 6, 2017

 

NONWARFARIN ORAL ANTICOAGULANTS (NOACS): THE CLINICAL PHARMACIST'S PERSPECTIVE

Few topics are as relevant - or of as intense interest - to contemporary pharmacy practice as the appropriate use of nonwarfarin oral anticoagulants (NOACs) approved by the FDA in January 2015. NOACs offer distinct advantages over warfarin; they have a rapid onset of action, more predictable pharmacologic profiles, and significantly reduced food and drug interactions. This activity offers education for clinical pharmacists on the latest evidence surrounding the different indications for NOACs, proper dosing strategies, management of bleeding, counseling patients on the safe use of NOACs (and how they differ from warfarin), managing and monitoring for food-drug and drug-drug interactions, and managing care transitions.

This activity expired for credit on March 18, 2017

 

UPDATES IN CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: THE ONCOLOGY NURSE AND ONCOLOGY NURSE PRACTITIONER'S PERSPECTIVES

Chemotherapy-induced nausea and vomiting (CINV) is a highly debilitating side effect of chemotherapy. CINV is common, causing symptoms in up to 30% of all patients who undergo chemotherapy, and occurring in up to 90% of patients who receive highly emetogenic agents such as cisplatin-, doxorubicin-, and cyclophosphamide-containing regimens. The American Society of Clinical Oncology (ASCO) voted modern antiemetic therapy as one of the top 10 advances in modern oncology because antiemetic therapy is an advance that marked one of the "major turning points for cancer care and improved and saved the lives of countless Americans." In this interactive video webinar advanced practice oncology NPs and oncology RNs share and discuss their extensive and unique experiences in managing patients suffering from or at risk of developing CINV, including nuances of antiemetic agents and experiential strategies for positioning antiemetic therapies, as well as how to educate patients regarding CINV and its prevention and treatment.

This activity expired for credit on December 15, 2016

 

NEW APPROACH TO LYMPHOMAS: TARGETING CD30

Targeted agents for the treatment of CD30-expressing lymphomas, including Hodgkin lymphoma and systemic and cutaneous T-cell lymphomas, has entered the clinic with several strategies in late-stage clinical trials. However, there is a lack of knowledge of how to best manage patients with CD30-expressing lymphoma based on disease characteristics and new treatment approaches. This monograph includes an in-depth discussion of the current and emerging treatment of CD30-expressing lymphomas. In addition, the mechanism of action of the antibody-drug conjugate, brentuximab vedotin, and management considerations of patients taking brentuximab vedotin will be explored with commentary from experts in the field of lymphoma.

This activity expired for credit on December 4, 2016

 

CONSIDERATIONS IN THE CLINICAL USE OF NON-WARFARIN ORAL ANTICOAGULATION IN THROMBOSIS

Nonwarfarin oral anticoagulants (NOACs) have emerged as key therapies to prevent and/or treat potentially deadly thrombotic conditions including stroke or systemic embolic events in patients with nonvalvular atrial fibrillation and venous thromboembolism. Although NOACs offer many advantages over conventional therapies, confusion over certain aspects of their safe and effective use in clinical practice persist. This educational activity will provide the latest data and recommendations in a case-based format to help guide the appropriate and confident use of NOACs in a variety of scenarios commonly encountered in clinical practice.

This activity expired for credit on November 9, 2015

 

ANTICOAGULATION IN THE EMERGENCY DEPARTMENT: A CASE-BASED APPROACH TO MANAGING PATIENTS WITH VENOUS THROMBOEMBOLISM AND NONVALVULAR ATRIAL FIBRILLATION

This live, interactive continuing medical education program will review current evidence and strategies for applying the information to confidently make appropriate "real-time" patient-centered treatment decisions in the emergency department with regard to the use of oral anticoagulation, and in particular the nonwarfarin oral anticoagulants. Key information will be presented in the context of patient case scenarios with the opportunity for participants to have their questions addressed by faculty. Topics include red flags for recognition and efficient diagnosis of nonvalvular atrial fibrillation and venous thromboembolism in the emergency department, balanced risk assessment for thrombosis and bleeding, choosing among available oral anticoagulants, and new strategies for managing acute bleeding events.

This activity expired for credit on February 26, 2017

 

CLINICAL PHARMACISTS AND CHRONIC HEART FAILURE: UNDERSTANDING THE ROLE OF NEW AND ESTABLISHED THERAPIES

This initiative will define chronic heart failure (CHF) with reduced ejection fraction (HFrEF or systolic HF) and will provide visual information and expert instruction to help clinical pharmacists differentiate between CHF/HFrEF and CHF with preserved ejection fraction (HFpEF, or diastolic heart failure). Faculty will review existing algorithms for the use of established cardiovascular drugs in treating CHF/HFrEF and describe the mechanisms of action, approved or proposed indications, and role of new and emerging agents in the treatment of CHF/HFrEF. The information presented will be vital to clinical pharmacists who are assuming an ever increasing role on the CHF treatment team.

This activity expired for credit on February 24, 2017

 

A PATIENT-CENTERED APPROACH TO CHRONIC LYMPHOCYTIC LEUKEMIA: NEW PERSPECTIVES ON MEDICAL MANAGEMENT, QUALITY OF LIFE, AND PSYCHOSOCIAL CARE

This program reviews the diagnosis and staging of chronic lymphocytic leukemia (CLL), current practices in the pharmacotherapy of CLL, and the status of agents in development. It also describes how CLL affects patients' and caregivers' emotional and mental well-being and takes an in-depth look at how clinicians can measure the impact of the disease on healthcare-related quality of life (HRQoL) and improve patient HRQoL.

This activity expired for credit on February 15, 2016

 

RECENT ADVANCES AND EMERGING TRENDS IN ONYCHOMYCOSIS MANAGEMENT: A SERIES OF LIVE CME SATELLITE SYMPOSIA AND AN ENDURING ON-DEMAND WEBINAR

Onychomycosis - a chronic infectious disease with significant medical and psychosocial consequences - can be extremely challenging to eradicate. To manage onychomycosis effectively, clinicians need to understand the etiology, diagnosis, and management of onychomycosis as a chronic infectious disease. They must also understand the characteristics of current topical, systemic, and mechanical treatments and be able to appropriately integrate new and emerging therapies into their practice based on treatment benefits and risks and patient factors. This initiative was designed to educate dermatologic clinicians on recent advances and emerging trends in onychomycosis management based on evidence from clinical trials, data on newer antifungal agents, and expert opinion and recommendations.

This activity expired for credit on February 23, 2017

 

ADVANCES IN ATOPIC DERMATITIS: EXPERT INSIGHTS INTO NEW AND EMERGING THERAPIES

Atopic dermatitis (AD) is a chronic, inflammatory, relapsing disorder that can result from a number of different factors including genetics, immune system dysfunction, and possibly environmental exposures. Because there is no known cure, treating patients with AD can be challenging and often frustrating for both the clinician and the patient. This CME provides information on the role of immune abnormalities and skin-barrier dysfunction in the development of AD and how this understanding informs and can help guide treatment selection. Expert faculty will discuss the 2014 AAD guidelines and other recent guidelines for diagnosis and management of AD, and summarize data on current and emerging topical and systemic therapies to help providers optimize treatment outcomes.

This activity expired for credit on November 30, 2016

 

ADVANCING THE CARE OF POST-ACNE SCARRING: EXPERT INSIGHTS INTO NEW TREATMENT OPTIONS

Optimal management of patients with atrophic facial scars of acne vulgaris requires mindfulness of the patient's psychosocial burden; familiarity with the latest evidence-based data on efficacy and safety of available treatment modalities; and the ability to match a patient's skin type, unique scar formation, and desired outcomes with the most appropriate treatment. During this CME-accredited activity, a panel of experts will address barriers to optimal treatment through presentations integrating didactic content with video case studies that include relevant demonstrations of patient assessment and treatment.

This activity expired for credit on May 11, 2017

 

TYPE 2 DIABETES MANAGEMENT: CURRENT GUIDELINES AND DECIPHERING THE LATEST THERAPY OPTIONS.

An individualized approach to management of type 2 diabetes mellitus (T2DM) may be the most likely tactic for achieving the best outcomes for any given T2DM patient, but it poses a challenge to clinicians with limited time and resources, especially given the ever-expanding armamentarium of antidiabetic drugs - including the incretin-based classes (GLP-1 receptor agonists and DPP-4 inhibitors), SGLT2 inhibitors, and combination agents. This CME-certified web monograph, which includes faculty audio clips and interactive questions, was designed to help guide appropriate treatment selection based on the T2DM patient's clinical characteristics, therapeutic goals, and patient's preference.

This activity expired for credit on August 13, 2016

 

TRUST YOUR GUT: IMPROVING THE PHYSICIAN ASSISTANT'S ACUMEN IN IDENTIFYING AND MANAGING IRRITABLE BOWEL SYNDROME AND CHRONIC IDIOPATHIC CONSTIPATION

Using a combination of didactic text, realistic case studies, interactive questions, and audio clips voicing the perspectives of our diverse PA, gastroenterologist, and patient faculty, this web monograph will immerse PAs in current, evidence-based approaches to identifying and managing IBS and CIC and provide strategies for improved patient-clinician communication-widely recognized as a cornerstone of optimal care. Knowledge of these advances, coupled with the patient-centered care PAs are known for, has the potential to greatly elevate both health outcomes and patient satisfaction.

This activity expired for credit on October 15, 2016

 

DUAL ORAL ANTIPLATELET THERAPY FOR ACS: IMPROVING STANDARDS OF CARE TO OPTIMIZE OUTCOMES

This live CME-certified symposium at the AHA Scientific Sessions 2014 was designed for cardiologists and interventional cardiologists, primary care physicians, hospitalists, fellows, PAs, NPs, and other healthcare providers caring for patients with ACS. It reviewed the latest guidelines for dual oral antiplatelet therapy for patients presenting with ACS and described recent data on these therapies in patients with UA/NSTEMI and STEMI.

Based on the live presentation, the CME/CE-certified enduring webinar is intended for cardiologists, interventional cardiologists, emergency department physicians, primary care physicians, hospitalists, fellows, PAs, NPs, and other healthcare professionals caring for or interested in the management of patients with ACS.

This activity concluded on July 1, 2014

 

SHARPENING FIBROMYALGIA DIAGNOSIS AND MANAGEMENT SKILLS: IMPROVING THE PATIENT EXPERIENCE

This CME/CE-certified, on-demand webinar was designed for primary care practitioners and other clinicians who manage patients with fibromyalgia. During the presentation, 2 expert clinicians, a patient with fibromyalgia, and a representative of a fibromyalgia patient advocacy group discuss and debate criteria that suggest a diagnosis of fibromyalgia, evidence-based pharmacologic and nonpharmacologic treatment strategies, and communication strategies to improve active listening and foster and open dialogue with these patients.

This activity expired for credit November 11, 2014

 

IMPROVING PATIENT CARE: NEW DIAGNOSTIC TECHNOLOGY FOR RAPID DETECTION OF COMMON INFECTIOUS DIARRHEAL AGENTS

This interactive, enduring CME-certified webinar - presented by 3 expert faculty, a gastroenterologist, an infectious disease specialist, and a microbiologist - was designed to increase clinician awareness of new same-day, single-specimen diagnostic assays. It enabled clinicians to identify patients who are candidates for testing and interpret test results according to assay performance characteristics and limitations.

This activity expired for credit on January 24, 2015

 

THE EVOLVING ROLE OF BETA BLOCKERS IN THE MANAGEMENT OF HYPERTENSION: EXPERT PERSPECTIVES

This CME-certified, enduring on-demand webinar was comprised of short didactic presentations and an extended roundtable discussion among presenters. The webinar, hosted by Paradigm, was promoted via several mechanisms, including a robust email campaign to Paradigm's growing internal database of learners, and distributed through PeerAudience's OpenCME Network.

This activity expired for credit on January 30, 2015

 

HYPONATREMIACME.ORG

This interactive website, dedicated to providing continuing education for physicians and other healthcare providers on the management of hyponatremia, includes case-based interactive webinars, text-based learning modules, and other online learning tools.

 

THE INFECTIOUS DISEASE SPECIALIST AS THE CATALYST FOR INFORMED ANTI-INFECTIVE DECISION MAKING IN THE HOSPITAL SETTING: FOCUS ON CABP AND ABSSSI

This live, interactive, case-based CME symposium following the Official Programming of the 49th Annual Meeting of the IDSA was videotaped and then developed into an interactive on-demand webinar hosted on Paradigm's website. Both activities presented vital information on the optimal management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in the hospital setting, with particular attention to the role of new anti-infective agents.

This activity expired for credit on January 5, 2014

 

CORE STRATEGIES FOR MANAGING CABP: OPTIMIZING CLINICAL RESOURCES AND EVIDENCE TO MEET JOINT COMMISSION/CMS QUALITY MEASURES

This case-based CME webcast was launched in May 2012. The Q&A Session consisted of questions identified by the faculty as well as pertinent questions from previous programs on CABP. The webcast was hosted and distributed on the Paradigm website and distributed via a number of methods including CECity's Centricity Distribution Network.

This activity expired for credit on July 25, 2014

 

THE ROLE OF THE CLINICAL PHARMACIST AS A CATALYST FOR APPROPRIATE ANTIBIOTIC DECISION-MAKING IN 2012 AND BEYOND: FOCUS ON CABP AND ABSSSI

This live, case-enhanced, audience-interactive CME satellite symposium at the ACCP 2012 Annual Meeting was targeted to clinical pharmacists. An enduring, case-enhanced, interactive web monograph, developed based on the live symposium, was hosted and distributed by Power-Pak C.E.

This activity expired for credit on January 27, 2014

 

COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: INPATIENT STRATEGY FOR HOSPITALISTS

This live, CME-certified, case-based, interactive satellite symposium at the SHM's 2013 Annual Meeting included challenging real-world clinical cases interspersed with didactic lectures and audience participation technology. The enduring, on-demand web activity, featuring an interactive text-based format of faculty presentations and discussions, was based on the proceedings of the live symposium. The enduring activity was hosted on The Hospitalist's website, www.the-hospitalist.org (an official website of the SHM), and cross-linked to www.paradigmmc.com.

This activity expired for credit on September 10, 2014

 

OUT WITH THE OLD? IN WITH THE NEW? BAD BUGS, NEW DRUGS, AND ANTIMICROBIAL STEWARDSHIP

This live, interactive CME satellite symposium, presented at IDWeek™ 2014, included didactic lectures and in-depth moderated Q&A between attendees and faculty focusing on optimal treatment strategies for the management of hospital-acquired infections frequently associated with MDROs and new and emerging treatment aligned with the tenets of antimicrobial stewardship. The enduring web monograph, developed from the proceedings of the live symposium, was hosted on the Paradigm website, www.paradigmmc.com, and distributed via Paradigm and Elsevier on the MEDLINE-indexed American Journal of Infection Control website, as well as other appropriate web portals.

This activity expired for credit on January 19, 2016

 

WHY CARE ABOUT SEASONAL INFLUENZA IN THE AGE OF EBOLA?

This enduring CME web monograph, developed by Paradigm and Global Education Group, provides clinicians with evidence-based faculty discussion to help them better understand the virus and learn about high risk populations, influenza-associated complications, prevention, and treatment. Available through February 2016 at www.paradigmmc.com/a396e, the activity is designed for physicians, nurses, NPs, PAs, and other clinicians who care for patients with chronic diseases who may be at high risk for consequences of seasonal influenza.

This activity expired for credit on February 18, 2016

 

EPISODIC AND CHRONIC MIGRAINE HEADACHE: BREAKING DOWN BARRIERS TO OPTIMAL TREATMENT AND PREVENTION

This CME initiative, led by 2 experts with clinical expertise in migraine management, includes a print and online supplement to Headache: The Journal of Head and Face Pain, the official journal of the American Headache Society. The 16-page print version was polybagged and distributed to all subscribers along with a monthly issue. The online version, converted into an interactive web monograph, includes hyperlinks to video vignettes and other important references and resources. The online version was posted on www.headachejournal.org and the neurology portal of www.paradigmmc.com.

This activity expired for credit January 31, 2016

 

EPISODIC AND CHRONIC MIGRAINE HEADACHES: TRANSFORMING SCIENCE INTO CLINICAL SUCCESS

This case-based, on-demand webinar discusses differential diagnosis, proper utilization of the latest guidelines and new agents in the treatment of migraine. It incorporates didactic presentation, video lecture, and case-enhanced vignettes with embedded videos to illustrate unique delivery systems and management techniques. The webinar is hosted on Paradigm's website, www.paradigmmc.com, and distributed via myCME. The live portion of this activity includes a series of meetings with didactic lecture, real-world case studies, and a hands-on workshop focusing on therapies with unique delivery systems.

 

A MEN'S HEALTH INITIATIVE: FOCUS ON MALE HYPOGONADISM AND TESTOSTERONE REPLACEMENT THERAPY

This enduring, CME-certified web monograph was branded by Urology ("The Gold Journal") and hosted on www.goldjournal.net. The web monograph was MEDLINE-indexed and distributed by Elsevier via email blasts, print and banner ads to their mix of Urology and Internal Medicine Journals. The webinar was followed by a live CME-certified satellite symposium, held in conjunction with the Southeast Section meeting of the AUA in March 2014.

This activity expired for credit on November 7, 2014

 

MULTIDISCIPLINARY APPROACH TO CHARTING A TREATMENT COURSE FOR MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: A CASE CONSULTS™ WEB ACTIVITY

This CME/CE-certified Case Consults™ video webinar includes a short overview discussion among the multidisciplinary faculty about the challenges in treating mCRPC followed by interactive patient cases. Designed to increase participant ability to apply a comprehensive set of monitoring parameters and make rational, evidence-based treatment decisions for their patients with metastatic castration-resistant prostate cancer based on current clinical evidence and guidelines, the activity is accessible via the Paradigm website, www.paradigmmc.com; the University of Cincinnati's CME website, www.cme.uc.edu; and the myCME website, www.myCME.com.

This activity expired for credit on June 30, 2016

 

ADVANCES IN IMMUNOTHERAPY FOR ADVANCED MELANOMA: INTEGRATING INTRALESIONAL AND ANTI-PD-1 IMMUNOTHERAPIES INTO CURRENT PRACTICE

This CME-certified satellite symposium at the Society of Surgical Oncology (SSO) 2015 Annual Meeting included didactic presentations, interactive case presentations, and a moderated Q&A discussion with the faculty panel. Throughout the symposium, attendees used iPads to view the program, take notes, interact with faculty, and complete the posttest, increasing audience interaction. An enduring audio webinar based upon the proceedings of the live symposium is hosted on www.paradigmmc.com.

This activity expired for credit on May 22, 2016

 

IMPROVING OUTCOMES IN PATIENTS WITH REFRACTORY IDIOPATHIC AND NEUROGENIC DETRUSOR OVERACTIVITY: MANAGEMENT STRATEGIES AND PATIENT PERSPECTIVES

Neurogenic detrusor overactivity (NDO) is commonly seen in patients who have neurologic conditions such as spinal cord injury, multiple sclerosis, Parkinson's disease, and cerebrovascular accident/stroke - who are commonly managed by physiatrists - physical medicine and rehabilitation specialists. NDO has significant medical, economic, and social impact, yet management remains suboptimal. This program provided participants with information on diagnosis and evidence-based treatment strategies, as well as expert insight on how, as members of a multidisciplinary care team, they can help reduce the burden of NDO by integrating patient perspectives into management plans.

This activity expired for credit on August 31, 2016.

 

NAILING THE CURE: ADVANCING THE MANAGEMENT OF ONYCHOMYCOSIS

This CME initiative was designed to educate dermatologists and dermatology and podiatry residents who treat and manage patients with onychomycosis about the importance of correct diagnosis and appropriate treatment of this common condition as well as the benefits and limitations of new and emerging treatment agents and how to integrate them into current protocols to optimize results.

This activity expired for credit on July 31, 2015

 

EVIDENCE-BASED MANAGEMENT OF ADVANCED GASTRIC CANCER: CURRENT AND EMERGING TARGETED THERAPIES

These live CME oncology grand rounds activities included didactic lecture, real-world case studies, and a question-and-answer session with an expert faculty presenter. An interactive CME/CE enduring web monograph, features key educational messages and video vignettes from the live meetings. Hosted on the Paradigm website, www.paradigmmc.com, the activity was also distributed via Elsevier on the MEDLINE-indexed Seminars in Oncology website (www.seminoncol.org) and other appropriate journal and web portals, and posted on the website of the International Society of Gastrointestinal Oncology (www.isgio.org).

This activity expired for credit on August 14, 2015

 

MANAGING CHRONIC CONSTIPATION AND IBS WITH CONSTIPATION: NEW EVIDENCE OF OVERLAP, DISTINCTIONS, AND IMPROVED TREATMENT STRATEGIES

This live, interactive CME/CE satellite symposium at the Digestive Disease Week 2014 discussed the incidence, impact, and patient management strategies for CC and IBS-C for GI specialists, including differential diagnosis, review of evidence-based guidelines, current therapeutic options, and appropriate use of novel and emerging treatments. An enduring, interactive web monograph was developed from the proceedings of the live symposium to extend the reach to clinicians unable to attend the meeting.

This activity expired for credit on July 25, 2015

 

TYPE 2 DIABETES TREATMENT FOR DIVERSE POPULATIONS: INTEGRATING NEW AND EMERGING AGENTS

This live CME symposium, held in conjunction with the American Diabetes Association 74th Scientific Sessions 2014, was developed for healthcare professionals actively involved in the management of patients with diabetes. The dynamic faculty discussion focused on the consequences of inadequate diabetes management as well as characteristics of the incretin-based therapies and SGLT2 inhibitors, including their extraglycemic effects. The enduring on-demand CME/CE webinar further advanced the educational impact and reach of the program.

This activity expired for credit on July 10, 2015

 

ADVANCING THE TREATMENT STRATEGIES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: THE UROLOGIST'S ROLE

This text-based, interactive, CME-certified web monograph features audio and video clips of expert faculty interviews and discussions and was designed to provide urologists, medical and radiation oncologists, and other healthcare professionals with the latest information on monitoring parameters that may help guide treatment decisions or indicate efficacy of therapy. The faculty also provide information on differences among available therapies to facilitate evidence-based, individualized treatment decisions and the roles of multidisciplinary team members in managing mCRPC patients.

This activity expired for credit on August 3, 2016

 

MELANOMACARE.ORG

This interactive website served as the platform for the many components of the Melanoma Care Coalition, an award-winning, comprehensive, multidisciplinary educational initiative designed for medical oncologists, surgical oncologists, dermatologists, oncology nurses, and other healthcare professionals caring for patients with melanoma. This initiative was developed and implemented in collaboration with the University of Pittsburgh School of Medicine.

 

2012 MELANOMA CARE COALITION WEBINAR SERIES

This series of CME/CNE-certified on-demand-webinars, available at www.melanomacare.org, focused on the pivotal issues that clinicians face in the care of patients with melanoma, such as advances in immunotherapy, management of metastatic melanoma, chemotherapy of melanoma, updates on emerging therapies, management, and biomarkers of melanoma.

 

DIABETIC RETINOPATHY AND RELATED EYE DISORDERS: NEW DEVELOPMENTS IN DIAGNOSIS AND TREATMENT

This text-based, case-enhanced, interactive, CME-certified web monograph includes links to relevant audio clips derived from a recorded faculty teleconference. It is hosted on the Paradigm website, www.paradigmmc.com and is also being distributed via Healio's Ophthalmology and Optometry websites, www.healio.com/ophthalmology, online home of Ophthalmic Surgery, Lasers and Imaging, Retina and Ocular Surgery News, and www.healio.com/optometry.

This activity expired for credit on September 4, 2016

 

CLARIFYING THE ROLE OF NOVEL AND EMERGING TREATMENTS FOR DIABETIC RETINOPATHY AND RELATED EYE DISORDERS

This live, interactive, CME-certified symposium will be held at the AAO 2015 Annual Meeting, November 14-17, 2015 and will incorporate didactic lectures, interactive patient case studies, videos of injection techniques, and in-depth moderated Q&A between attendees and faculty. Throughout the symposium, attendees will use iPads, provided by Educational Measures, to view the program, take notes, and interact with faculty. An enduring, text-based, interactive web monograph, including links to relevant audio and video from the live ancillary symposium, will be hosted on the Paradigm website, www.paradigmmc.com, and distributed via Paradigm as well as Healio's Ophthalmology Education Lab website, www.healio.com/ophthalmology, online home of Ophthalmic Surgery, Lasers and Imaging and Retina and Ocular Surgery News.

This activity expired for credit on January 29, 2017

 

INDIVIDUALIZED TREATMENT OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA: A CASE-BASED GUIDE TO APPLYING NEW DATA

This series of 3 Case Consults™ CME Web Activities offers a serial learning design consisting of 3 digitally-delivered quarter-hour case activities designed to enhance clinical skill development of retina specialists managing DR and DME. Using the RealCME platform, each activity will utilize text, faculty audio clips, dynamic tools for interdisciplinary communication, and instructional intravitreal injection videos to guide learners through interactive patient case studies, where they will be required to respond to questions at critical decision points in the course of treatment. This web initiative will be distributed by Paradigm and PeerAudience's OpenCME Network.

Case Scenario 1: Proliferative Diabetic Retinopathy and Diabetic Macular Edema

Case Scenario 2: Diabetic Macular Edema

Case Scenario 3: Refractory Diabetic Macular Edema

This activity expired for credit on October 30, 2016

 

CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ENHANCING THE BREADTH OF OUTPATIENT CARE FROM DIAGNOSIS THROUGH MANAGEMENT

This CME/CE-certified webinar features short didactic presentations followed by extended roundtable discussions among experts in the field of pulmonary medicine, geared toward the office-based practitioner (PCPs, PAs, NPs, and community pulmonologists). In addition, a demonstration of the appropriate use of currently available COPD management agents and equipment is available for clinician/patient viewing, along with other clinician and patient education tools. The webinar, hosted by Paradigm, was promoted via several mechanisms, including a robust email campaign to Paradigm's internal database of learners, and distribution through PeerAudience's OpenCME Network.

This activity expired for credit on December 26, 2014

 

CHRONIC OBSTRUCTIVE PULMONARY DISEASE: IMPROVING CARE AND PATIENT OUTCOMES

COPD is placing a strain on health care systems nationwide. One reason is that exacerbations of COPD are all too common, leading to excessive rehospitalizations. A leading pulmonologist discusses evidence-based strategies for diagnosing COPD, managing exacerbations, and choosing from the many medication options when planning treatment.

This activity expired for credit on October 15, 2016

 

MITIGATING STROKE RISK ACROSS THE CONTINUUM OF CARE: THE ROLE OF TARGETED ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION

This enduring on-demand CME webinar included didactic and case-based discussions presented in a roundtable format and involved experts from the specialties of cardiology, emergency medicine, primary care, and clinical pharmacy. The webinar was hosted on www.paradigmmc.com, and was promoted via several mechanisms, including a robust email campaign to Paradigm's internal database of learners and distribution through PeerAudience's OpenCME Network.

This activity expired for credit on August 11, 2015

 

HOSPITALISTS ON THE FRONTLINE: PREVENTING AND MANAGING THROMBOEMBOLIC EVENTS

This live, interactive CME satellite symposium, presented at Hospital Medicine 2015, included didactic lectures, in-depth moderated Q&A between attendees and faculty, and patient education resources. An enduring web monograph developed from the proceedings features the most clinically relevant content and additional resources such as patient education materials. The interactive CME-certified web monograph is accessible via the Paradigm website, www.paradigmmc.com, the HQF website, and the website for The Hospitalist, www.the-hospitalist.org.

This activity expired for credit on March 31, 2015

 

KEY UPDATES IN MANAGING ORAL ANTICOAGULATION AND ITS REVERSAL

This series of text- and audio-video-enabled CME/CPE-certified quarterly web newsletters will report on the latest developments in the field of thrombosis management, featuring summaries of important presentations at major medical conferences and embedded interviews with leading clinicians, researchers, and opinion leaders in the field of anticoagulation. These web newsletters will be accessible via the Paradigm website, www.paradigmmc.com, and the Hospital Quality Foundation (HQF) website, www.hospitalqualityfoundation.org and will be distributed quarterly by Paradigm, HQF, and Elsevier.

January 2016 Issue:
This activity expired for credit on January 22, 2017

September 2015 Issue:
This activity expired for credit on September 18, 2016

 

ANTICOAGULATION THERAPY IN PRIMARY CARE: KEEPING YOUR FINGER ON THE PULSE OF CURRENT CLINICAL RECOMMENDATIONS

Atrial fibrillation (AF) is the most common and important cardiac arrhythmia encountered in clinical practice. Even with the availability in recent years of 4 non-warfarin oral anticoagulants (NOACs), many at-risk patients are not assessed or treated appropriately due in part to confusion about where these agents fit in clinical practice. Due to pharmacodynamic and pharmacokinetic differences among the agents, patient-specific risk factors such as renal clearance must be taken into consideration when prescribing an NOAC. This activity has been designed to help primary care clinicians identify at-risk patients with AF, conduct an evidence-based work-up, and develop individualized treatment plans that appropriately utilize newer therapies when indicated.

This activity expired for credit on December 30, 2016